Viewing Study NCT01510561


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-14 @ 2:22 AM
Study NCT ID: NCT01510561
Status: WITHDRAWN
Last Update Posted: 2021-08-19
First Post: 2012-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module